Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02604836 · ClinicalTrials.gov registry record · Phase 4
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Phase 4 study of Postmenopausal Osteoporosis, sponsored by Hoffmann-La Roche.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,711
- Enrollment target
- 20
- Study locations
NCT02604836: Completed Phase 4 study of Postmenopausal Osteoporosis, sponsored by Hoffmann-La Roche.
NCT02604836 is a Phase 4 study of Postmenopausal Osteoporosis that has completed, run by Hoffmann-La Roche. The registered enrollment target is 1,711 participants, above the 399-participant average among 14 other Postmenopausal Osteoporosis trials with a reported enrollment target (329% higher). The trial reports 20 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02604836, a Phase 4 study of Postmenopausal Osteoporosis, has completed, sponsored by Hoffmann-La Roche.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,711 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study will investigate participant satisfaction (including compliance, preference, tolerability) with once-monthly Bonviva in women with post-menopausal osteoporosis or osteopenia transitioned from once-weekly alendronate or risedronate. The anticipated time on study treatment is 6 months, and the target sample size is 1776 individuals.
Conditions Studied
Interventions
- DRUG Ibandronate
Study Locations (20)
Arizona
- - Chandler
- - Gilbert
- - Paradise Valley
- - Phoenix
- - Phoenix
- - Tempe
- - Tucson
Arkansas
- - Carlisle
- - Jonesboro
- - Little Rock
- - Pine Bluff
- - Rogers
- - Searcy
- - Sherwood
Alabama
- - Birmingham
- - Columbiana
- - Huntsville
- - Mobile
- - Montgomery
California
- - Anaheim
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,711 participants |
| Start Date | 2004-06 |
| Est. Completion | 2006-04 |
| Phase | Phase 4 |
What the finished NCT02604836 record still lists
NCT02604836 is an interventional study that assigns participants to a tested intervention. Its 1,711 participants enrollment target places it among the larger protocols in the corpus, above the 399-participant average among 14 other Postmenopausal Osteoporosis trials with a reported enrollment target (329% higher).
The record links to 1 condition, with Postmenopausal Osteoporosis appearing as the primary indexed condition, and to 1 intervention - of which Ibandronate is the first listed.
NCT02604836 names 20 study sites across 4 states, led by Arizona, Arkansas, Alabama.
Frequently Asked Questions
What is clinical trial NCT02604836 about?
NCT02604836 is a clinical study titled "A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia". This study will investigate participant satisfaction (including compliance, preference, tolerability) with once-monthly Bonviva in women with post-menopausal osteoporosis or osteopenia transitioned from once-weekly alendronate or risedronate. The anticipated time on study treatment is 6 months, and ...
What is the current status of trial NCT02604836?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,711 participants. The study started on 2004-06. Estimated completion is 2006-04.
What conditions does trial NCT02604836 study?
This clinical trial studies the following conditions: Postmenopausal Osteoporosis.
What interventions are being tested in trial NCT02604836?
The interventions under investigation include: Ibandronate (DRUG).
Who is sponsoring clinical trial NCT02604836?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02604836 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postmenopausal Osteoporosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02604836's enrollment target sits among peer trials
1,711 1st of 14 higher than 14 of 14 other Postmenopausal Osteoporosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postmenopausal Osteoporosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Anabolic Therapy in Postmenopausal Osteoporosis
ACTIVE NOT RECRUITING · Phase 4
-
PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopenia
COMPLETED · Phase 4
-
A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)
COMPLETED · Phase 4
-
Dried Plums and Bone Health in Postmenopausal Women
ACTIVE NOT RECRUITING · NA
-
A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS)
ACTIVE NOT RECRUITING · Phase 2
-
Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05303636 · 1,710 participants · Phase 4
LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women
- NCT04291612 · 1,715 participants
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
- NCT07304531 · 1,705 participants
First To Know Pregnancy Test - Clinical Evaluation Protocol
- NCT04321200 · 1,700 participants
PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia